Abbott Laboratories (ABT) Invested Capital (2009 - 2026)

Abbott Laboratories has disclosed Invested Capital across 18 years of filings, most recently posting $84.4 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 31.28% year-over-year to $84.4 billion; the TTM figure through Jun 2026 stood at $84.4 billion (up 31.28% YoY), while the FY2025 annual figure was $65.7 billion, up 3.42% from the prior year.
• Invested Capital came in at $84.4 billion for Q2 2026 at Abbott Laboratories, down from $86.7 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $86.7 billion in Q1 2026 to a low of $52.3 billion in Q3 2022.
• Average Invested Capital over 5 years is $60.3 billion, with a median of $54.8 billion recorded in 2023.
• Year-over-year, Invested Capital dropped 2.4% in 2023 and soared 39.23% in 2026.
• Over 5 years, Invested Capital stood at $55.9 billion in 2022, then slipped by 2.4% to $54.6 billion in 2023, then climbed by 16.38% to $63.5 billion in 2024, then grew by 3.42% to $65.7 billion in 2025, then advanced by 28.42% to $84.4 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $84.4 billion in Q2 2026, $86.7 billion in Q1 2026, and $65.7 billion in Q4 2025.